{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-072407","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.444202+00:00","generated_at":"2026-06-01T04:54:01.868530+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Monte Rosa Therapeutics 2024 annual meeting results: directors elected, auditor ratified","bullets":["Markus Warmuth, M.D. elected with 39,473,886 votes for, 84,415 withheld; Ali Behbahani, M.D. with 23,794,947 for, 15,763,354 withheld.","Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 approved: 40,409,003 for, 59,893 against, 3 abstentions.","No other matters were submitted to a vote at the June 12, 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-072407","json":"https://secwatch.observer/filing/0000950170-24-072407.json","markdown":"https://secwatch.observer/filing/0000950170-24-072407.md","text":"https://secwatch.observer/filing/0000950170-24-072407.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/0000950170-24-072407-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/glue-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:54:01.868530+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}